Seban, R.-D.; Donnadieu, A.; Journo, G.; Bidard, F.-C.; Richard, C.; Rouzier, R.; Champion, L.
18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab. Diagnostics 2021, 11, 1353.
https://doi.org/10.3390/diagnostics11081353
AMA Style
Seban R-D, Donnadieu A, Journo G, Bidard F-C, Richard C, Rouzier R, Champion L.
18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab. Diagnostics. 2021; 11(8):1353.
https://doi.org/10.3390/diagnostics11081353
Chicago/Turabian Style
Seban, Romain-David, Anne Donnadieu, Gabrielle Journo, Francois-Clement Bidard, Capucine Richard, Roman Rouzier, and Laurence Champion.
2021. "18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab" Diagnostics 11, no. 8: 1353.
https://doi.org/10.3390/diagnostics11081353
APA Style
Seban, R. -D., Donnadieu, A., Journo, G., Bidard, F. -C., Richard, C., Rouzier, R., & Champion, L.
(2021). 18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab. Diagnostics, 11(8), 1353.
https://doi.org/10.3390/diagnostics11081353
